Green Cross Medical Science Corporation (142280) — Cash Flow-to-Debt Ratio
Green Cross Medical Science Corporation (142280) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2026, meaning its operating cash flow of ₩-714.99 Million could theoretically repay 0% of its total liabilities (₩40.86 Billion) in one year. See 142280 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Green Cross Medical Science Corporation Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Green Cross Medical Science Corporation across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does Green Cross Medical Science Corporation generate cash.
Annual Cash Flow-to-Debt Ratio for Green Cross Medical Science Corporation (2014–2025)
Year-by-year debt coverage analysis for Green Cross Medical Science Corporation. Check 142280 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | ₩7.20 Billion | ₩44.14 Billion | ▲ +108.2% |
| 2024 | 0.08x | ₩3.66 Billion | ₩46.76 Billion | ▼ -1.0% |
| 2023 | 0.08x | ₩4.24 Billion | ₩53.61 Billion | ▼ -54.0% |
| 2022 | 0.17x | ₩10.88 Billion | ₩63.22 Billion | ▲ +156.3% |
| 2021 | -0.31x | ₩-18.20 Billion | ₩59.51 Billion | ▼ -71.5% |
| 2020 | -0.18x | ₩-8.76 Billion | ₩49.14 Billion | ▼ -70.5% |
| 2019 | -0.10x | ₩-4.11 Billion | ₩39.29 Billion | ▼ -884.2% |
| 2018 | -0.01x | ₩-516.61 Million | ₩48.63 Billion | ▼ -112.8% |
| 2017 | 0.08x | ₩3.11 Billion | ₩37.31 Billion | ▼ -70.1% |
| 2016 | 0.28x | ₩10.25 Billion | ₩36.76 Billion | ▲ +323.9% |
| 2015 | -0.12x | ₩-5.45 Billion | ₩43.74 Billion | ▼ -15.6% |
| 2014 | -0.11x | ₩-2.22 Billion | ₩20.60 Billion | — |